Vanguard Group Inc Arcturus Therapeutics Holdings Inc. Transaction History

Vanguard Group Inc

  • $5.37 Trillion
  • Q1 2025

A detailed history of Vanguard Group Inc transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,748,928 shares of ARCT stock, worth $21.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,748,928
Previous 1,684,561 3.82%
Holding current value
$21.9 Million
Previous $28.6 Million 35.21%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025
BUY
$10.59 - $20.83 $681,646 - $1.34 Million
64,367 Added 3.82%
1,748,928 $18.5 Million
Q4 2024

Feb 11, 2025
BUY
$14.82 - $25.48 $1.6 Million - $2.74 Million
107,635 Added 6.83%
1,684,561 $28.6 Million
Q3 2024

Nov 13, 2024
BUY
$18.08 - $25.38 $3.47 Million - $4.88 Million
192,182 Added 13.88%
1,576,926 $36.6 Million
Q2 2024

Aug 13, 2024
SELL
$24.35 - $44.39 $76,702 - $139,828
-3,150 Reduced 0.23%
1,384,744 $33.7 Million
Q1 2024

May 10, 2024
SELL
$31.23 - $42.99 $2.2 Million - $3.03 Million
-70,486 Reduced 4.83%
1,387,894 $46.9 Million
Q4 2023

Feb 14, 2024
BUY
$17.71 - $32.97 $912,720 - $1.7 Million
51,537 Added 3.66%
1,458,380 $46 Million
Q3 2023

Nov 14, 2023
SELL
$25.44 - $37.35 $5.64 Million - $8.28 Million
-221,573 Reduced 13.61%
1,406,843 $35.9 Million
Q2 2023

Aug 14, 2023
BUY
$23.94 - $32.36 $3.9 Million - $5.28 Million
163,070 Added 11.13%
1,628,416 $46.7 Million
Q1 2023

May 15, 2023
BUY
$14.72 - $23.97 $219,637 - $357,656
14,921 Added 1.03%
1,465,346 $35.1 Million
Q4 2022

Feb 10, 2023
BUY
$14.14 - $23.06 $1.61 Million - $2.62 Million
113,607 Added 8.5%
1,450,425 $24.6 Million
Q3 2022

Nov 14, 2022
BUY
$13.05 - $22.13 $1.87 Million - $3.17 Million
143,162 Added 11.99%
1,336,818 $19.8 Million
Q2 2022

Aug 12, 2022
BUY
$12.26 - $31.17 $492,153 - $1.25 Million
40,143 Added 3.48%
1,193,656 $18.8 Million
Q1 2022

May 13, 2022
BUY
$17.64 - $39.57 $110,973 - $248,934
6,291 Added 0.55%
1,153,513 $31.1 Million
Q4 2021

Feb 14, 2022
BUY
$34.2 - $47.56 $1.14 Million - $1.58 Million
33,271 Added 2.99%
1,147,222 $42.5 Million
Q3 2021

Nov 12, 2021
SELL
$27.88 - $58.25 $1.84 Million - $3.84 Million
-65,890 Reduced 5.58%
1,113,951 $53.2 Million
Q2 2021

Aug 13, 2021
BUY
$25.79 - $42.11 $30.4 Million - $49.7 Million
1,179,841 New
1,179,841 $39.9 Million

Others Institutions Holding ARCT

# of Institutions
161
Shares Held
26.5M
Call Options Held
312K
Put Options Held
96.5K
View Full List

About Arcturus Therapeutics Holdings Inc.

ARCT Quotes by TradingView
  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $333M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email